Therapy (HCV)
"Preferential Virological Response to Interferon-Alpha(2a) in Patients with Chronic Hepatitis C Infected by Virus Genotype 3a and Exhibiting a Low Gamma-GT/ALT Ratio."
Published in Hepatitis Weekly, August 5th, 1996
According to the authors' abstract of an article published in Digestive Diseases and Sciences, "Hepatitis C virus infection causes acute and often chronic hepatitis. Therapy with interferon-alpha has been shown to induce remission of the inflammatory process within the liver and also elimination of the virus. However, only about 50% of treated patients respond in terms of at least a transient disappearance of viral RNA from the circulation below the limit of detection. In order to find prognostic factors for responsiveness, patients with chronic hepatitis C virus infection were analyzed for virus genotype and pretreatment biochemical liver parameters including serum AST, ALT, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-08-05)
More Articles from Hepatitis Weekly
- Therapy (HCV)
Gradually Reducing IFN Results in Better HCV Treatment - Diagnostics (HBV)
Anti-HBc is Marker of HBV Infection in HIV+ - Immunology
Plasmid Constructs with HCV Core Protein is Potential Therapy - Industry News (Patents and Technologies)
U.S. Patent on 3TC Awarded to Emory University - Risk Factors
Low Risk for Hepatitis Among Child Care Providers Reported - Testing (HCV)
HCV Test Needed in Those with Neuropathy/Mixed Cryoglobulinemia - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
